About: Miguel Angel Chávez Fumagalli

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Miguel Angel Chávez Fumagalli Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Peruvian veterinarian

Attributes	Values
rdf:type	Item
description	研究者 (ja) araştırmacı (tr) дослідник (uk) 研究者 (zh) onderzoeker (nl) investigador peruanu (ast) Peruvian veterinarian (en) طبيب بيطري بيروي (ar) veterinario peruano (es)
rdfs:label	Miguel A Chávez-Fumagalli (nl) Miguel A Chávez-Fumagalli (sl) Miguel A Chávez-Fumagalli (ast) Miguel Angel Chávez Fumagalli (en) Miguel Angel Chávez Fumagalli (es)
skos:prefLabel	Miguel A Chávez-Fumagalli (nl) Miguel A Chávez-Fumagalli (sl) Miguel A Chávez-Fumagalli (ast) Miguel Angel Chávez Fumagalli (en) Miguel Angel Chávez Fumagalli (es)
name	Miguel A Chávez-Fumagalli (nl) Miguel A Chávez-Fumagalli (sl) Miguel A Chávez-Fumagalli (ast) Miguel Angel Chávez Fumagalli (en) Miguel Angel Chávez Fumagalli (es)
Scopus author ID	wds:Q83313550-34E2CDB0-E3BB-497C-9A23-51D462671DE7
Scopus author ID	35271437900
given name	wds:Q83313550-F71B5944-01B4-4F7B-B5A9-4AC4EB8B91B6 wds:q83313550-e8f4ff12-4767-a1a2-d89f-d27038e1cb0a
given name	Angel Miguel
instance of	wds:Q83313550-1FCFC4CD-2D40-47C0-877E-0BC28E0D4BF6
instance of	Homo sapiens
ResearchGate profile ID	wds:Q83313550-2FFEA08E-EE68-4308-A22E-C35CE767B740
ResearchGate profile ID	Miguel_Chavez_Fumagalli
skos:altLabel	Miguel Chávez Fumagalli (en) Miguel Chávez Fumagalli (es)
occupation	wds:Q83313550-1FFA3C00-D92B-4877-8FC9-C6F493EF9C1A wds:Q83313550-7a25d1e0-4206-f548-6e0e-e7439225523c
employer	wds:Q83313550-1D679BD7-520E-43AD-8AB5-87993523D18C wds:Q83313550-BA95363F-2873-4333-BC50-58FC1D3BEA40
languages spoken, written or signed	wds:Q83313550-1da20147-42bf-e5c3-1003-59b65c3941ad wds:Q83313550-3422aae8-4bb6-e3b8-9d75-cfeb5197116e wds:Q83313550-3ab60ba0-4ac6-d2e6-4524-e226511f1bb1 wds:Q83313550-746fb0e9-4aeb-d2ac-da33-2eb421041017
second family name in Spanish name	wds:q83313550-39797d36-4a6e-9306-80cb-d993611f907f
sex or gender	wds:Q83313550-376d2fb7-632b-4d3d-b170-d8980cef0eb9
country of citizenship	wds:Q83313550-2532c33c-b730-4d40-973c-d57898ae8098
educated at	wds:Q83313550-2A81430C-9AA2-462B-AE6D-99D89978F483 wds:Q83313550-35D5E3F4-9BCC-4572-851B-61349F5FFF71 wds:Q83313550-889A62E5-8DEB-4A0D-97F3-30D66387B445
family name	wds:q83313550-24e8ce75-49e6-48f5-b740-153331b938c3
occupation	veterinarian researcher
employer	Federal University of Minas Gerais Catholic University of Santa María
languages spoken, written or signed	Spanish French English Portuguese
second family name in Spanish name	Fumagalli
sex or gender	male
country of citizenship	Peru
educated at	Federal University of Minas Gerais Federal Rural University of Pernambuco
family name	Chávez
ORCID iD	wds:Q83313550-BD8E7768-D64D-441E-8A54-BDE7614FF34F
ORCID iD	https://orcid.org/0000-0002-8394-4802
ORCID iD	0000-0002-8394-4802
ResearcherID	wds:Q83313550-2308B5AF-CBFA-4602-9E56-8DF4CE997EE9
ResearcherID	I-6756-2016
Renacyt ID	wds:Q83313550-1a266fc6-dfdc-49ea-8b17-b98e096734ce
Renacyt ID	0019490
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q83313550
is author of	Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis. Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approach New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment. Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species. Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis. Correction: Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis. Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis. Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites Antileishmanial activity and cytotoxicity of Brazilian plants Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications. New serological tools for improved diagnosis of human tegumentary leishmaniasis. Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts. Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial Activity Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis. A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis. Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 182 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software